Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00MEM
|
||||
Former ID |
DNC006751
|
||||
Drug Name |
H-Dmt-Tic-Gly-NH-CH2-Bid
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528269] | ||
Structure |
Download2D MOL |
||||
Formula |
C31H34N6O4
|
||||
Canonical SMILES |
CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCC(=O)NCC4<br />=NC5=CC=CC=C5N4)N)C)O
|
||||
InChI |
1S/C31H34N6O4/c1-18-11-22(38)12-19(2)23(18)14-24(32)31(41)37-17-21-8-4-3-7-20(21)13-27(37)30(40)34-16-29(39)33-15-28-35-25-9-5-6-10-26(25)36-28/h3-12,24,27,38H,13-17,32H2,1-2H3,(H,33,39)(H,34,40)(H,35,36)/t24-,27-/m0/s1
|
||||
InChIKey |
LKKOHYJIXKBADA-IGKIAQTJSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [528269] | |
Delta-type opioid receptor | Target Info | Inhibitor | [528269] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.